Search clinical trials for: SAR339658

Total 4 results

Genzyme, a Sanofi Company

Terminated

Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839

Relapsing-remitting Multiple Sclerosis

Russian Federation, United States, Canada, Poland
Sanofi

Terminated

Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)

Ulcerative Colitis

United States
Sanofi

Terminated

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis (FUSCIA)

Ulcerative Colitis

United States, Austria, Canada, France, Germany, Italy, Poland
Genzyme, a Sanofi Company

Terminated

Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis (EMPIRE)

Relapsing-remitting Multiple Sclerosis

Sweden, Poland, Russian Federation, United States, Canada

3

Subscribe